Earnings Scheduled For March 29, 2022
Companies Reporting Before The Bell
• 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
NexImmune (NASDAQ:NEXI) stock moved upwards by 8.3% to $3.51 during Monday's after-market session. This security traded at a volume of 109.1K shares come close, making up 76.6% of its average volume over the last 100 days. The company's market cap stands at $80.1 million.
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
50 Stocks Moving In Friday’s Mid-Day Session
Gainers
Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday.
Watching Checkpoint Therapeutics; Traders Circulate TipRanks Report Titled ‘2 “Strong Buy” Penny Stocks With Over 300% Upside Potential;’ Article Also Mentions CorMedix
https://blog.tipranks.com/2-strong-buy-penny-stocks-with-over-300-upside-potential/
CorMedix Refiles DefenCath US Application For Catheter-Related Bloodstream Infections
CorMedix Inc (NASDAQ: CRMD) has resubmi
Cormedix Inc. Announces Resubmission Of New Drug Application For DefenCath
CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has
Cormedix’s Return On Capital Employed Insights
According to Benzinga Pro data, during Q2, Cormedix (AMEX:CRMD) posted sales of $8.19 thousand. Earnings were up 18.42%, but Cormedix still reported an overall loss of $5.88 million.
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: